Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells

Cancer Immunology Immunotherapy

Volumn 45, Issue 1, 1997, Pages 45-52

  Bruserud, Øystein ^a   Pawelec, Graham ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Acute myelogenous leukaemia; Interleukin 13; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 2; MITOGENIC AGENT; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR;

ACCESSORY CELL; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BLAST CELL; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD4; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION, VIRAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-2; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STIMULATION, CHEMICAL; T-LYMPHOCYTES;

EID: 0030873745     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050399     Document Type: Article

References (33)

1. + T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood 88:3522
2. Bruserud Ø (1996) The effect of interleukin 13 on constitutive cytokine secretion by acute myelogenous leukemia blasts. Leukemia 10:1497
3. Bruserud Ø, Hamann W, Patel S, Ehninger G, Pawelec G (1992) IL2- and IL4-dependent proliferation of Tcell clones derived early after allogeneic bone marrow transplantation: studies of patients with chronic myelogenous leukaemia. Eur J Haematol 48:221
4. + TCRαβ+ T cell clones derived early after allogeneic bone marrow transplantation. Scand J Immunol 38:65
5. + T-cell clones derived early after allogeneic bone marrow transplantation. Eur J Haematol 51:73
6. + T cell clones derived from leukaemia patients. Eur J Haematol 54:106
7. Bruserud Ø, Mentzoni L, Foss B, Bergheim J, Berentsen S, Nesthus I (1996) Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon γ secretion. Cancer Immunol Immunother 43:275
8. Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78:2791
9. Essayan DM, Han W-F, Li X-M, Xiao H-Q, Kleine-Tebbe J, Huang S-K (1996) Clonal diversity of IL4 and IL13 expression in human allergen-specific T lymphocytes. J Allergy Clin Immunol 98:1035
10. Fiedler W, Suciu E, Wittlief C, Ostertag W, Hossfeld DK (1990) Mechanisms of growth factor expression in acute myeloid leukemia (AML). Leukemia 4:459
11. Gambacorti-Passerini C, Grignani F, Arienti F, Pandolfi PP, Pelicci PG, Parmiani G (1993) Human CD4 T lymphocytes specifically recognize the fusion region of the hydride protein pml/RARα present in acute promyelocytic leukaemia cells. Blood 81:1369
12. Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, Besien KV, Khouri I, Mehra R, Przopiorka D, Körbling M, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R (1995) CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood 86:4337
13. Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR (1995) Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T cell depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86:3987
14. Ijzermans JNM, Marquet RL (1989) Interferon-gamma: a review. Immunobiology 179:456
15. + Th0, Th1 and Th2 cell clones and EBV-transformed B cells. Int Immunol 7:1405
16. Mastriani DM, Tung NM, Tenen DG (1992) Acute myelogenous leukemia: current treatment and future directions. Am J Med 92:286
17. Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, Callard R (1995) Function of the interleukin 2 (IL2) receptor γ chain in biological responses of X-linked severe combined immunodeficient B cells to IL2, IL4, IL13 and IL15. Blood 85:38
18. McKenzie ANJ, Zurawski G (1995) Interleukin 13: characterization and biological properties. Cancer Treat Res 80:367
19. Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D (1993) Inlerleukin 13: a novel human cytokine regulating inflammatory and immune responses. Nature 362: 248
20. Velardi A, Varese P, Terenzi A, Dembech C, Albi N, Grossi CE, Moretta L, Martelli MF, Grignani F, Mingari MC (1989) Lymphokine production by T cell clones after human bone marrow transplantation. Blood 74:1665
21. Niederwieser D, Grassegger A, Aubock J, Herold M, Nachbaur D, Rosenmayr A, Gächter A, Nussbaumer W, Gaggl S, Ritter M, Huber C (1993) Correlation of minor histocompalibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 81:2200
22. Obiri NI, Debinski W, Leonard WJ, Puri RK (1995) Receptor for Interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9 and 15. J Biol Chem 270:8797
23. Pawelec G (1994) Immune surveillance in leukemia: rationale for immunotherapy. Hematol Rev 8:123
24. Pawelec G, Max H, Halder T, Bruserud Ø, Merl A, Silva P da, Kalbacher H (1996) BCR/ABL leukemia oncogen fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the reperoire of normal donors. Blood 88:2118
25. Pawelec G, Rehbein A, Schlotz E, Silva P da (1996) Cellular immune responses to autologous chronic myelognous leukaemia cells in vitro. Cancer Immunol Immunther 42:193
26. Romagnani S (1991) Human Th1 and Th2 subsets: doubt no more. Immunol Today 12:256
27. Russell NH (1992) Autocrine growth factors and leukaemic hematopoiesis. Blood Rev 6:149
28. Sissolak G, Hoffbrand AV, Mehta AB, Ganeshaguru K (1992) Effects of interferon γ on the expression of interleukin β, interleukin 6, granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in acute myeloid leukemia blasts. Leukemia 6:1155
29. Tony H-P, Shen B-J, Reusch P, Sebald W (1994) Design of human interleukin 4 antagonists inhibiting interleukin 4-dependent and interleukin 13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem 225:659
30. Vallenga E, deWolf JTM, Beentjes JAM, Esselink MT, Smit JW, Halie MR (1990) Divergent effects of interleukin 4 on the granulocyte colony-stimulating factor and IL3-supported myeloid colony formation from normal and leukaemia bone marow cells. Blood 75:633
31. Jacobsen SE, Okkenhaug C, Veiby OP, Caput D, Ferrara P, Minty A (1994) Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 180:75
32. Zurawski SM, Vega F, Huyghe B, Zurawski G (1993) Receptors for interleukin 13 and interleukin 4 are complex and share a novel component that functions in signal transduction. EMBO J 12:2663
33. Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie ANJ, Miossec P, Banchereau J, Zurawski G (1995) The primary binding subunit of the human Interleukin 4 receptor is also a component of the interleukin 13 receptor. J Biol Chem 270:13869